Development of Dual-Targeting CAR-T Cells for Enhanced Specificity and Efficacy in Solid Tumors

Research Proposal: Development of Dual-Targeting CAR-T Cells for Enhanced Specificity and Efficacy in Solid Tumors Jeya Chelliah B.Vsc Ph.D. Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematological malignancies, achieving remarkable success in patients with acute lymphoblastic leukemia (ALL) and

Unraveling the Complexity: Why Neoantigens Pose Challenges for Cancer Immunotherapy

by Jeya Chelliah B.Vsc Ph.D. Today, we embark on a journey into the intricate world of cancer immunotherapy, specifically focusing on a topic that has stirred both curiosity and skepticism: neoantigens. Neoantigens, the altered protein fragments unique to cancer cells, have garnered attention